The incidence of Herpesvirus hominis antibody in the population
about
The changing disease-scape in the third epidemiological transitionHerpetic whitlow: a medical riskCharacterization of genital strains of Herpesvirus hominis.Incidence of Herpesvirus hominis antibodies among blood donor populations.Herpesvirus hominis antibodies among children and young adults in IbadanHerpesvirus hominis type 2 infection in Ibadan. Problem of non-venereal transmissionPrevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection.Herpesviruses.The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991.Herpes simplex virus infections of women and their offspring: implications for a developed society.Antibodies to Herpesvirus hominis types 1 and 2 in malnourished Nigerian children.The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes.First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology.Seroepidemiology of herpes simplex virus in Yogyakarta, Indonesia.Serological evidence of herpes simplex virus infection in atopic eczema.Antibody responses in humans to individual proteins of herpes simplex viruses.Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease.Evidence for a viral neuropathy in recurrent vertigo.Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.Enzyme immunoassay for measurement of antibodies to herpes simplex virus infection: comparison with complement fixation, immunofluorescent-antibody, and neutralization techniquesComparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.Herpesvirus hominis infections in renal transplant recipients.Humoral immunity to herpes simplex viral-induced antigens in smokers.Age-specific incidence of neutralization antibodies of Herpes simplex virus.Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice.Herpes type-2 virus antibodies in Nigerian children.Virucidal activity of chlorhexidine on strains of Herpesvirus hominis, poliovirus, and adenovirus.Necrotising balanitis due to a generalised primary infection with herpes simplex virus type 2.Trench mouth in children.Two laboratory methods for diagnosis of herpes simplex keratitisImmunity to viral infections among medical students in LondonExperimental ulcerative herpetic keratitis. I. Systemic immune responses and resistance to corneal infection.The incidence of complement-fixing antibody to varicella-zoster virus in hospital patients and blood donors.Use of antibiotics and antifungal agents in herpetic gingivostomatitis.Experimental viral arthritis induced with herpes simplex.Herpes simplex virus infection in the media of donor corneas during organ culture: frequency and consequences.Incidence of antibody to EB virus, herpes simplex, and cytomegalovirus in Hodgkin's disease.Seroepidemiology of herpes simplex virus type 1 in Yanji, Jilin, China.Viral epidemiology: the hidden universality of infection.
P2860
Q17485683-5B869446-79FB-494F-A19C-C57D4157BE97Q24674619-FF177C68-3035-49B2-B735-3E219B24811CQ33654071-083F6B7C-EDA7-4040-BD91-B45E616344FAQ33654845-DDDFCF95-5DEC-4088-B19C-DE45D6313E67Q33656266-FA2D740F-59BE-484E-B2ED-5B2DF0279B13Q33657169-E36AF20A-9DDB-480D-98FB-1814C2086A08Q33687109-337E512F-57F1-41FA-986A-DEED507F4FA2Q33847479-95AE867A-4E57-44B5-9323-29F2EC5B09E8Q33934554-F8FD1A3D-81B7-4F60-ADAD-C556A1D5EBFBQ35114519-F0B62BC3-0B9A-4FD4-B26E-7B6C511E29C7Q35114805-E9F8F648-5846-4210-BC01-E93E1C745B7CQ35528404-ADE37E23-2FE3-4537-82BA-B80B1D9E1CEBQ35528603-230A25DD-5B97-45F9-8604-9F4F849A8A8BQ35537467-5AE9BCA2-366B-4783-9011-9E5A28A9C5F4Q35603759-CDEC8533-FBB6-4690-8C11-A2FA8EAB36E3Q36432263-90A35BA3-AE26-4491-A7EB-3BCE7A4A0684Q36605681-21E93446-F042-44B8-81E0-D5DCDA94C9C7Q37072245-E54830A7-F96C-43CE-84B6-7454E2A4DC51Q37213893-DF9DFA2B-F4EA-48B6-8B24-BC20E5899C1EQ37322559-5295D9B3-28BA-418E-9809-92302A98DE55Q37352632-1AD80355-02ED-4E7A-B50E-0226521B8A28Q39939574-3D2C9BDF-51B7-48DC-8625-62FCB45F1E00Q40006731-370BB2F2-F9EF-438D-A133-08FD2366F4B9Q40020962-C8954FFE-CB55-4D09-8428-3EBD44E24555Q40072940-28750B0B-86DE-4FE4-AA3A-CB892048E99DQ40117855-5CDF5AE6-AC9D-48AE-8995-5A4214415071Q41256351-677D0D1D-4CF3-4E6C-AAB0-F2ACE49610D0Q41485151-C78E2D33-ED93-4422-AF35-4BBDB5D35CA3Q41944691-EA5F76C1-6093-45E4-A28B-3F18C54BB7AAQ42009702-DEFD2768-6BBA-497B-8ABE-D416D6070D40Q42600121-FB1FE457-EB3F-41C1-8A5B-886C7B72FADBQ42606590-A3B2DE4B-56E4-4C18-B21C-369D5D0230D0Q42791875-4647BCA2-40E2-4B5C-955A-6CEB5C70DEBEQ43208425-FCD9A2ED-A845-4FCA-8A0C-35CE54085F37Q44071400-C16ACD31-98CB-4BD1-A0A3-1927BB3D88B5Q45734843-434575C7-14B3-4960-8A47-D542F8F407D1Q45822400-AFDB148C-0B35-4FCC-839C-9935F316FD2EQ45850794-B3A1DDE4-4DA7-4167-9E70-5817CDDA4E5DQ50333988-E57DFA81-D4A7-412D-9479-07A613FE7B56
P2860
The incidence of Herpesvirus hominis antibody in the population
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年論文
@yue
1967年論文
@zh-hant
1967年論文
@zh-hk
1967年論文
@zh-mo
1967年論文
@zh-tw
1967年论文
@wuu
1967年论文
@zh
1967年论文
@zh-cn
name
The incidence of Herpesvirus hominis antibody in the population
@ast
The incidence of Herpesvirus hominis antibody in the population
@en
type
label
The incidence of Herpesvirus hominis antibody in the population
@ast
The incidence of Herpesvirus hominis antibody in the population
@en
prefLabel
The incidence of Herpesvirus hominis antibody in the population
@ast
The incidence of Herpesvirus hominis antibody in the population
@en
P2093
P2860
P1476
The incidence of Herpesvirus hominis antibody in the population
@en
P2093
MacCallum FO
Peutherer JF
P2860
P304
P356
10.1017/S0022172400045915
P577
1967-09-01T00:00:00Z